AI Science Tracker
EN

Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach

Not stated in the reviewed material · 26 May 2021 · medicine

Discovery

Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Specific clinical biomarker/severity result arises from measured COVID cohort and ML analysis with comparison groups; qualifies narrowly as retrospective clinical result. Version is non-peer-reviewed v1 and association does not establish causation.

Technology: Machine Learning

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Original v1 Methods: retrospective 126 PCR-confirmed hospitalized COVID-19 patients, 50 healthy and 45 pre-pandemic hospital controls; measured PON1/inflammatory markers and ML variable selection/classification assess severity. Results support specific PON1-related variables and inflammatory biomarkers differentiating severity groups. Preprint, single-center, retrospective; markers are associations, not causal or prospective predictors.
Limitation / still unknown
Affiliation not stated in the reviewed material. Affiliation was not available in the reviewed primary bibliographic metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.preprints.org/manuscript/202105.0623/v1/download

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.